Published 3 months ago • loading... • Updated 3 months ago

Processa Pharmaceuticals Announces Successful Completion of $5 Million Public Offering

Summary by themarketsdaily.com

Hanover, Maryland – January 30, 2025 – Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) disclosed today the closing of its recent public offering, generating approximately $5.0 million in gross proceeds for the company. The healthcare-focused institutional investor participated in the offering, which included the sale and issuance of 1,030,972 shares of common stock, Series A and Series […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All

Left

Center

Right

modernreaders.com

+2 Reposted by 2 other sources

Processa Pharmaceuticals Announces Successful Completion of $5 Million Public Offering

3 months ago

Read Full Article

stocktitan.net

Processa CEO Doubles Down: Purchases Shares at 30% Premium in $5M Strategic Raise

Processa Pharmaceuticals completes $5M public offering with notable insider buying at premium prices, backed by healthcare investors and existing stakeholders. Includes strategic warrant structure.

3 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year